Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,530 total articles
TTM Technologies (TTMI) sits at the intersection of AI infrastructure and defense electronics. Recent quarterly strength, an accretive European acquisition announcement, and an attractive technical setup argue for a tactical long. Valuation is rich on P/E but reasonable on revenue exposure; risk centers on cyclicality, execution on M&A integration,…
Penguin Solutions appears positioned to benefit from enterprise AI infrastructure upgrades. With accelerating revenue growth, healthy gross margins and a cash-rich balance sheet, the company looks capable of delivering outsized upside over a mid-term swing. This is a tactical long idea sized for disciplined risk management.
Arista Networks (ANET) looks richly valued by traditional metrics, but its dominant position in high-speed data-center networking, strong profitability and an $8.9B backlog argue for a constructive long position over the next 180 trading days. This trade idea lays out exact entry, stop and target levels, the thesis drivers and the risks that could …
Memory markets are bifurcating. Micron looks poised to out-earn expectations from DRAM tailwinds while SanDisk exposure to NAND faces ongoing price pressure. This pair trade captures that dispersion: long Micron (MU) and short SanDisk exposure through Western Digital (WDC/Sandisk legacy) with clear entries, stops and targets for a mid-term (45 trad…
Tesla's surprise delivery beat and expansion of Robotaxi services materially change the near-term growth trajectory. The company still trades at a premium, but accelerating unit volume, intact free cash flow and manageable leverage create a favorable risk-reward for a tactical long. I upgrade to a buy and lay out an actionable trade plan for the ne…
MasTec (MTZ) sits squarely in the path of AI-driven demand for power, fiber and construction. Revenue acceleration, healthy cash generation and a manageable balance sheet justify a long idea today despite elevated multiples. This trade plan proposes a market-entry at $382.45, a stop at $335.00 and a $440.00 target over a long-term (180 trading days…
SpaceX presents a counterintuitive setup: bond investors demand junk yields while the equity offers an asymmetric upside if operational momentum continues. I recommend a tactical long on ticker SPCX with a tight stop and a multi-month horizon to let Starlink ARPU gains and launch cadence play out.
Palantir has been richly valued for years, but recent weakness has cleared out momentum traders and left a fundamentally stronger company trading at an entry point that suits a patient, conviction-weighted trade. Strong revenue growth, high margins and meaningful free cash flow justify a tactical long with a clear stop and a 180-day target.
XPeng’s recent delivery rebound (40,126 vehicles in June) plus new model pre-sales and an aggressive international marketing push make a compelling case that the stock has put in a cyclical bottom. At a market cap of ~$12.5B and a share price near $13.12, the risk/reward favors a mid-term long trade while monitoring autonomous and regulatory headli…
Marvell’s pivot from commodity controllers to custom ASICs, DPUs and high-speed optical networking has matured into a scalable AI-infrastructure franchise. With a $202B market cap and FCF of $1.66B, the stock looks expensive on near-term multiples but remains supported by secular revenue/EBITDA CAGRs ~40% and a strategic $2B investment anchor. This…
Hims & Hers (HIMS) still trades like a busted growth story despite guiding to $2.8-3.0B in 2026 revenue and clear traction in GLP-1 fulfillment. Recent margin compression and a debt-funded acquisition dented sentiment, creating a tactical long opportunity with defined risk management for a mid-term swing.
Equinox has emerged as Canada’s second-largest gold producer. The combination of higher output, falling unit costs and a cleaner balance sheet positions the stock for a re-rating. This trade recommends a tactical long with a clear entry, stop and target tied to operational and macro catalysts.
Markets are pricing Oracle like a credit problem. The company is in the middle of one-time, debt-funded infrastructure spending to capture AI infrastructure demand — a bet that is already producing 90%+ cloud growth and a multi-hundred-billion dollar backlog. With a current price near $141.64, an oversold technical setup, and valuation metrics that…
AppLovin continues to deliver blowout growth, but the stock trades at premium multiples and recent insider selling plus heavy short activity raise the odds of a near-term pullback. This trade proposes a mid-term short on weakness with a clearly defined entry, stop and target while acknowledging the bull case and upside catalysts.
Ultra Clean Holdings fell nearly 15% after a sharp intra-week selloff. The company still sits on a $4.07B market cap, strong revenue run-rate and heavy exposure to AI-driven semiconductor demand. This trade idea lays out a mid-term swing buy at $90.86 with a $120 target and a $81 stop, explains the thesis, catalogs catalysts and risks, and states e…
Factorial Energy (FAC) is a speculative bet on solid-state battery commercialization. At roughly $1.04 billion market cap and a $10.04 share price, the stock has traded down from a $25.33 52-week high and now shows technical consolidation, elevated short activity and a valuation that still assumes execution risks. This trade idea targets a mid-term…
Nano Labs (NA) is a Hangzhou-based fabless semiconductor company focused on high-throughput and vision computing chips, distributed compute/storage, and AI hardware. Trading at $1.77 with a market cap of ~$41.1M, the stock looks materially cheap on headline multiples (PE 1.91, PB 0.39). This trade idea outlines a long bias into the company ahead of…
Robert Half (RHI) looks oversold after a year of sector weakness. Recent sequential revenue inflection, a chunky dividend yield near 7% and constructive technicals argue for a long position over the next 180 trading days. This trade lays out an entry, stop and $42 target while highlighting catalysts and clear risks.
ChargePoint is a high-risk, high-reward trade. The EV charging leader is unprofitable but trading at a sub-1x price-to-sales multiple with recent signs of margin recovery, an insider buy, and meaningful short interest that can fuel squeezes. This plan defines an entry at $5.85, a stop at $4.50 and a primary target of $12.00 over a 180-trading-day h…
Coherent plunged after a rapid re-rate, dragging price back toward levels that offer a favorable risk-reward for a tactical long. The company benefits directly from data center upgrades and AI compute build-outs, has a clean balance sheet, and still faces short-term technical weakness. We lay out an entry, stop, and target for a mid-term swing trad…
TransDigm (TDG) is a high-margin aerospace parts consolidator with sole-source positions and steady aftermarket cash flow. Market cap is ~$74.4B and EV ~$102.5B; the business is expensive but profitable (operating margin ~47.2%). This trade idea outlines an entry at $1330.00, a target of $1600.00 and a stop at $1150.00, with a long-term horizon (18…
ServiceNow's recent sell-off priced in a worst-case AI disruption scenario. Concrete signs — subscription growth, Now Assist revenue traction, healthy free cash flow and improving technicals — indicate the downside is overstated. This is a trade idea to buy NOW with a clear entry, stop and target over a swing horizon while controlling for execution…
Diageo trades near multi-year lows after a difficult patch for the spirits industry. At $82.81 the stock offers a sub-13x forward-like earnings multiple in many sell-side notes, a 3.97% yield, positive technical momentum and improving volume dynamics. Our actionable trade: buy at $82.81, stop $75.00, primary target $100.00, horizon ~mid-to-long pos…
Kura Oncology ($KURA) is trading near $12 after FDA approval and NCCN guideline inclusion for its menin inhibitor KOMZIFTI (ziftomenib). Positive early commercial signs, a Japanese registrational trial and encouraging combo data for other pipeline assets create multiple near-term catalysts. Valuation reflects a commercial-stage premium (market cap …
Perimeter Solutions reported a sharp rebound in sales and adjusted EBITDA after the MMT acquisition and a string of multi-year contracts. The setup looks actionable for a mid-term long: the business is re‑rating on better top-line growth, but leverage and an ongoing securities probe keep risk elevated. I lay out an entry, stop and target for a 45 t…
